About the DSCSA
The Drug Supply Chain Security Act (DSCSA) outlines critical steps to building an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States.
Why do we need a Drug Supply Chain Security Act?
The DSCSA was passed because the counterfeit medication market—a multi-billion dollar industry—accounts for more than a million deaths worldwide annually. This law outlines critical steps to building an electronic, interoperable system to identify and trace certain prescription drugs distributed in the United States and intends to hold accountable those who dispense medication to patients that is not legitimate. The DSCSA, which began affecting healthcare in March 2016, protects consumers from counterfeit prescription medication by requiring all healthcare organizations that dispense pharmaceuticals to:
- Identify and report potentially counterfeit and suspicious drugs.
- Track and trace drug products from manufacturing origin to final dispensing location.
Step by Step Guide to the DSCSA
In this presentation, we provide provide a step by step guide for Compliance, providing valuable information for your pharmacy and how to address 340B, Infusion Centers, and managing multiple affiliates within your system.
Please download the valuable information below, to make sure your facility is compliant.
Compliance with the DSCSA begins with drug manufacturers and continues to repackagers, wholesale distributors, dispensers and trading partners, defined as follows:
A wholesale distributor is an entity that provides the logistics to distribute prescription medication.
A dispenser is any healthcare entity or professional who prescribes or provides medication or uses medication in the treatment of a patient. Dispensers are pharmacists, physicians, emergency medical services, or pharmacies resident in hospitals, clinics and long-term and urgent care facilities.
A repackager breaks bulk or makes bulk of product purchased from a manufacturer or wholesale distributor.
Trading partners are dispensers that receive medication from other dispensers due to inventory problems or shortages.
RXTransparent is the first and only end-to-end DSCSA compliance solution that provides visibility and transparency throughout the entire drug supply chain.
Built in partnership with a Fortune 500 healthcare system, RXTransparent enables seamless tracking across real-world healthcare settings and scenarios, including transfers, borrow and trade, repackaging/off-label use and first responder resupply.